Company RedHill Biopharma Ltd. OTC Markets
Equities
REDIF
IL0011223810
Pharmaceuticals
Business Summary
Number of employees: 53
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial
100.0
%
| 62 | 100.0 % | 7 | 100.0 % | -89.43% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 62 | 100.0 % | 7 | 100.0 % | -89.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 09-08-02 |
Ori Shilo
FOU | Founder | 58 | 09-08-02 |
Razi Ingber
DFI | Director of Finance/CFO | - | 23-01-04 |
Gilead Raday
COO | Chief Operating Officer | 49 | 10-11-09 |
Ira N. Kalfus
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Reza Fathi
CTO | Chief Tech/Sci/R&D Officer | 69 | 10-04-30 |
kristin Comer
CMP | Compliance Officer | - | - |
June Almenoff
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-05-27 |
Mark L. Levitt
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Terry F. Plasse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 15-12-31 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 10-08-25 |
Director/Board Member | 80 | 10-05-02 | |
Alla Felder
BRD | Director/Board Member | 51 | 19-05-05 |
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 09-08-02 |
Kenneth Reed
BRD | Director/Board Member | 70 | 09-12-14 |
Ofer Tsimchi
BRD | Director/Board Member | 64 | 11-05-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,869,853,000 | 7,791,154,470 ( 99.00 %) | 0 | 99.00 % |
Company contact information
![address RedHill Biopharma Ltd.(REDIF)](https://cdn.zonebourse.com/static/address/120794093.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+7.90% | 101B | |
+8.42% | 42.18B | |
-13.04% | 32.26B | |
+80.80% | 29.79B | |
-10.92% | 16.06B | |
+1.93% | 14.45B | |
-6.77% | 12.01B | |
+177.16% | 10.71B | |
+4.12% | 8.89B |